| Better Evidence and Translation for Calciphylaxis (NCT05018221) | University of Sydney | 2021-08-26 |
| Phase 3 Study of SNF472 for Calciphylaxis (NCT04195906) | Sanifit Therapeutics S. A. | 2020-02-12 |
| Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis (NCT04592640) | The First Affiliated Hospital with Nanjing Medical University | 2018-09-17 |
| Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate (NCT03319914) | Hope Pharmaceuticals | 2017-10-20 |
| A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients (NCT03150420) | Hope Pharmaceuticals | 2017-05-24 |
| The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort (NCT03146793) | Centre Hospitalier St Esprit | 2017-05-01 |
| Partners Calciphylaxis Biobank (NCT03032835) | Massachusetts General Hospital | 2017-01-01 |
| Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome (NCT02854046) | Nantes University Hospital | 2016-07-01 |
| Phase 2 Study With SNF472 in Calciphylaxis Patients (NCT02790073) | Sanifit Therapeutics S. A. | 2016-05-01 |
| European Calciphylaxis Registry Network (NCT02635373) | RWTH Aachen University | 2015-12-01 |
| Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy (NCT02278692) | Massachusetts General Hospital | 2015-03-01 |
| Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy (NCT02527213) | American Regent, Inc. | 2015-01-30 |
| Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU) (NCT01578382) | University of Zurich | 2011-09-01 |
| Efficacy of Lanthanum Carbonate in Calciphylaxis (NCT01289626) | University of Wisconsin, Madison | 2011-02-01 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |